Find clinical trials for Multiple Sclerosis (MS) in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Paris, Île-de-France, FRA:
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Le Kremlin Bicetre, France and 73 other locations
This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...
Phase 3
Paris, France and 161 other locations
the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple...
Phase 3
Créteil, France and 36 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Le Kremlin Bicetre, France and 107 other locations
This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis...
Phase 4
Paris, France and 10 other locations
Centra nervous system (CNF) damage in multiple sclerosis (MS), are mainly attributed to myelin destruction, axonal abnorma...
Phase 2
Paris, France and 4 other locations
effects of alemtuzumab on other multiple sclerosis (MS) disease characteristics such as cognition and quality of life (Qo...
Phase 3
Le Kremlin Bicetre, France and 20 other locations
Treating cognitive impairment (CI) in multiple sclerosis (MS), the leading cause of disability due to nontraumatic neurolo...
Poissy, France and 6 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
Le Kremlin Bicêtre cedex, Val De Marne, France and 64 other locations
study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS...
Phase 3
Creteil, France and 40 other locations
Clinical trials
Research sites
Resources
Legal